Company: QXO-PB
Filing Date: 2025-04-16
Form Type: 424B5
Source: 0001140361-25-014221
Chunk: 96

Company: QXO, Inc.
Filing Date: 2025-04-16
Form: 424B5
Chunk 96
---
 raising additional equity or debt capital from public or private markets to pursue the Company’s business plan following the closing of the private placements, including potentially one or more additional private placements of common stock, and the effects that raising such capital may have on the Company and its business, including the risk of substantial dilution or that the Company’s common stock may experience a substantial decline in trading price; |

| • | the possibility that additional future financings may not be available to the Company on acceptable terms or at all; |

| • | the effect that the consummation of the private placements have had or may have on the Company and its current or future business or on the price of the Company’s common stock; |

| • | the possibility that an active, liquid trading market for the Company’s common stock may not develop or, if developed, may not be sustained; |

| • | the possibility that the Company’s outstanding warrants and preferred stock may or may not be converted or exercised, and the economic impact on the Company and the holders of common stock of the Company that may result from either such exercise or conversion, including dilution, or the continuance of the preferred stock remaining outstanding, and the impact its terms, including its dividend, may have on the Company and the common stock of the Company; |

| • | uncertainties regarding the Company’s focus, strategic plans and other management actions; |

| • | the risk that the Company is or becomes highly dependent on the continued leadership of Brad Jacobs as chairman and chief executive officer and the possibility that the loss of Mr. Jacobs in these roles could have a material adverse effect on the Company’s business, financial condition and results of operations; |

| • | the possibility that the concentration of ownership by Mr. Jacobs may have the effect of delaying or preventing a change in control of the Company and might affect the market price of shares of the common stock of the Company; |

| • | the risk that Mr. Jacobs’ past performance may not be representative of future results; |

| • | the risk that the Company is unable to attract and retain world-class talent; |

| • | the risk that the failure to consummate any acquisition expeditiously, or at all, could have a material adverse effect on the Company’s business prospects, financial condition, results of operations or the price of the Company’s common stock; |

| • | risks that the Company may not be able to enter into agreements with acquisition targets on attractive terms, or at all, that agreed acquisitions may not be consummated